Skip to main content

Advertisement

Log in

PLXNA3 Variant rs5945430 is Associated with Severe Clinical Course in Male Multiple Sclerosis Patients

  • Original Paper
  • Published:
NeuroMolecular Medicine Aims and scope Submit manuscript

Abstract

Multiple sclerosis (MS) exhibits sex bias in disease clinical course as male MS patients develop severe, progressive clinical course with accumulating disability. So far, no factors have been found associating with this sex bias in MS severity. We set out to determine the genetic factor contributing to MS male-specific progressive disease. This is an MS cross-sectional study involving 213 Kuwaiti MS patients recruited at Dasman Diabetes Institute. Exome sequencing was performed on 18 females and 8 male MS patients’ genomic DNA. rs5945430 genotyping was performed using Taqman genotyping assay. Estradiol levels were determined by enzyme-linked immunosorbent assay. Exome analysis revealed a missense variant (rs5945430) in Plexin A3 (PLXNA3) gene (Xq28) associated with male-specific MS severity. Genotyping of 187 MS patients for rs5945430 confirmed the association of rs5945430G with increased disease severity in MS males (p = 0.013; OR 3.8; 95% CI 1.24–11.7) and disability (p = 0.024). Estradiol levels shown to effect PLXNA3 expression were lower in MS males compared to MS females, and they were lower than control rs5945430G males (p = 0.057), whereas MS females had similar estradiol levels to healthy females reducing the level of expressed PLXNA3 GG in MS females. PLXNA3 rs5945430G is associated with increased disease severity in MS male patients. Estradiol is a possible protective factor against the expression of rs5945430G in MS females.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  • Al-Temaimi, R., Alroughani, R., Jacob, S., & Al-Mulla, F. (2015). Gender influence in EBV antibody response in multiple sclerosis patients from Kuwait. Journal of Neuroimmunology, 285, 57–61. doi:10.1016/j.jneuroim.2015.05.021.

    Article  CAS  PubMed  Google Scholar 

  • Bagri, A., Cheng, H. J., Yaron, A., Pleasure, S. J., & Tessier-Lavigne, M. (2003). Stereotyped pruning of long hippocampal axon branches triggered by retraction inducers of the semaphorin family. Cell, 113, 285–299.

    Article  CAS  PubMed  Google Scholar 

  • Barcellos, L. F., Sawcer, S., Ramsay, P. P., Baranzini, S. E., Thomson, G., Briggs, F., et al. (2006). Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Human Molecular Genetics, 15, 2813–2824. doi:10.1093/hmg/ddl223.

    Article  CAS  PubMed  Google Scholar 

  • Bashinskaya, V. V., Kulakova, O. G., Boyko, A. N., Favorov, A. V., & Favorova, O. O. (2015). A review of genome-wide association studies for multiple sclerosis: Classical and hypothesis-driven approaches. Human Genetics, 134, 1143–1162. doi:10.1007/s00439-015-1601-2.

    Article  CAS  PubMed  Google Scholar 

  • Bebo, B. F., Jr., Fyfe-Johnson, A., Adlard, K., Beam, A. G., Vandenbark, A. A., & Offner, H. (2001). Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains. J Immunol, 166, 2080–2089.

    Article  CAS  PubMed  Google Scholar 

  • Belyk, M., Kraft, S. J., Brown, S., Pediatric Imaging, N., & Genetics, S. (2015). PlexinA polymorphisms mediate the developmental trajectory of human corpus callosum microstructure. Journal of Human Genetics, 60, 147–150. doi:10.1038/jhg.2014.107.

    Article  CAS  PubMed  Google Scholar 

  • Bordon, Y. (2014). Autoimmunity: A breakthrough to explain sex bias? Nature Reviews Immunology, 14, 355. doi:10.1038/nri3696.

    Article  CAS  PubMed  Google Scholar 

  • Bove, R., Healy, B. C., Musallam, A., Glanz, B. I., De Jager, P. L., & Chitnis, T. (2015). Exploration of changes in disability after menopause in a longitudinal multiple sclerosis cohort. Mult Scler. doi:10.1177/1352458515606211.

    PubMed Central  Google Scholar 

  • Caruso, D., Melis, M., Fenu, G., Giatti, S., Romano, S., Grimoldi, M., et al. (2014). Neuroactive steroid levels in plasma and cerebrospinal fluid of male multiple sclerosis patients. Journal of Neurochemistry, 130, 591–597. doi:10.1111/jnc.12745.

    Article  CAS  PubMed  Google Scholar 

  • Cheng, H. J., Bagri, A., Yaron, A., Stein, E., Pleasure, S. J., & Tessier-Lavigne, M. (2001). Plexin-A3 mediates semaphorin signaling and regulates the development of hippocampal axonal projections. Neuron, 32, 249–263.

    Article  CAS  PubMed  Google Scholar 

  • Christianson, M. S., Mensah, V. A., & Shen, W. (2015). Multiple sclerosis at menopause: Potential neuroprotective effects of estrogen. Maturitas, 80, 133–139. doi:10.1016/j.maturitas.2014.11.013.

    Article  CAS  PubMed  Google Scholar 

  • Coleman, M. P., & Perry, V. H. (2002). Axon pathology in neurological disease: A neglected therapeutic target. Trends in Neurosciences, 25, 532–537.

    Article  CAS  PubMed  Google Scholar 

  • Confavreux, C., Hutchinson, M., Hours, M. M., Cortinovis-Tourniaire, P., & Moreau, T. (1998). Rate of pregnancy-related relapse in multiple sclerosis: Pregnancy in multiple sclerosis group. New England Journal of Medicine, 339, 285–291. doi:10.1056/NEJM199807303390501.

    Article  CAS  PubMed  Google Scholar 

  • Costa, C., Martinez-Saez, E., Gutierrez-Franco, A., Eixarch, H., Castro, Z., Ortega-Aznar, A., et al. (2015). Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions. Multiple Sclerosis Journal, 21, 1632–1643. doi:10.1177/1352458515599848.

    Article  CAS  PubMed  Google Scholar 

  • Duquette, P., Pleines, J., Girard, M., Charest, L., Senecal-Quevillon, M., & Masse, C. (1992). The increased susceptibility of women to multiple sclerosis. Canadian Journal of Neurological Sciences, 19, 466–471.

    CAS  PubMed  Google Scholar 

  • Fiedler, S. E., Schillace, R. V., Daniels, C. J., Andrews, S. F., & Carr, D. W. (2010). Myeloid translocation gene 16b is a dual A-kinase anchoring protein that interacts selectively with plexins in a phospho-regulated manner. FEBS Letters, 584, 873–877. doi:10.1016/j.febslet.2010.02.007.

    Article  CAS  PubMed  Google Scholar 

  • Filippi, M., Preziosa, P., Copetti, M., Riccitelli, G., Horsfield, M. A., Martinelli, V., et al. (2013). Gray matter damage predicts the accumulation of disability 13 years later in MS. Neurology, 81, 1759–1767. doi:10.1212/01.wnl.0000435551.90824.d0.

    Article  PubMed  Google Scholar 

  • Gomez, C., Burt-Pichat, B., Mallein-Gerin, F., Merle, B., Delmas, P. D., Skerry, T. M., et al. (2005). Expression of Semaphorin-3A and its receptors in endochondral ossification: Potential role in skeletal development and innervation. Developmental Dynamics, 234, 393–403. doi:10.1002/dvdy.20512.

    Article  CAS  PubMed  Google Scholar 

  • Gubbels Bupp, M. R. (2015). Sex, the aging immune system, and chronic disease. Cellular Immunology, 294, 102–110. doi:10.1016/j.cellimm.2015.02.002.

    Article  CAS  PubMed  Google Scholar 

  • International Multiple Sclerosis Genetics Consortium, and Wellcome Trust Case Control Consortium, Sawcer, S., Hellenthal, G., Pirinen, M., Spencer, C. C., et al. (2011). Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature, 476, 214–219. doi:10.1038/nature10251.

    Article  Google Scholar 

  • Ito, T., Morita, T., Yoshida, K., Negishi, T., & Yukawa, K. (2014). Semaphorin 3A-Plexin-A1 signaling through ERK activation is crucial for Toll-like receptor-induced NO production in BV-2 microglial cells. International Journal of Molecular Medicine, 33, 1635–1642. doi:10.3892/ijmm.2014.1727.

    Article  CAS  PubMed  Google Scholar 

  • Janssen, B. J., Robinson, R. A., Perez-Branguli, F., Bell, C. H., Mitchell, K. J., Siebold, C., et al. (2010). Structural basis of semaphorin-plexin signalling. Nature, 467, 1118–1122. doi:10.1038/nature09468.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ji, J. D., Park-Min, K. H., & Ivashkiv, L. B. (2009). Expression and function of semaphorin 3A and its receptors in human monocyte-derived macrophages. Human Immunology, 70, 211–217. doi:10.1016/j.humimm.2009.01.026.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kallaur, A. P., Kaimen-Maciel, D. R., Morimoto, H. K., Watanabe, M. A., Georgeto, S. M., & Reiche, E. M. (2011). Genetic polymorphisms associated with the development and clinical course of multiple sclerosis (review). International Journal of Molecular Medicine, 28, 467–479. doi:10.3892/ijmm.2011.731.

    CAS  PubMed  Google Scholar 

  • Kipp, M., Hochstrasser, T., Schmitz, C., & Beyer, C. (2016). Female sex steroids and glia cells: Impact on multiple sclerosis lesion formation and fine tuning of the local neurodegenerative cellular network. Neuroscience and Biobehavioral Reviews, 67, 125–136. doi:10.1016/j.neubiorev.2015.11.016.

    Article  CAS  PubMed  Google Scholar 

  • Kolk, S. M., Gunput, R. A., Tran, T. S., van den Heuvel, D. M., Prasad, A. A., Hellemons, A. J., et al. (2009). Semaphorin 3F is a bifunctional guidance cue for dopaminergic axons and controls their fasciculation, channeling, rostral growth, and intracortical targeting. Journal of Neuroscience, 29, 12542–12557. doi:10.1523/JNEUROSCI.2521-09.2009.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kremer, D., Hartung, H. P., & Kury, P. (2015). Targeting semaphorins in MS as a treatment strategy to promote remyelination: A tale of mice, rats and men. Multiple Sclerosis, 21, 1616–1617. doi:10.1177/1352458515608693.

    Article  CAS  PubMed  Google Scholar 

  • Lee, D. Y., Kim, K. A., Yu, Y. G., & Kim, K. S. (2004). Substitution of aspartic acid with glutamic acid increases the unfolding transition temperature of a protein. Biochemical and Biophysical Research Communications, 320, 900–906. doi:10.1016/j.bbrc.2004.06.031.

    Article  CAS  PubMed  Google Scholar 

  • Meroni, G., Franco, B., Archidiacono, N., Messali, S., Andolfi, G., Rocchi, M., et al. (1996). Characterization of a cluster of sulfatase genes on Xp22.3 suggests gene duplications in an ancestral pseudoautosomal region. Human Molecular Genetics, 5, 423–431.

    Article  CAS  PubMed  Google Scholar 

  • Okuno, T., Nakatsuji, Y., Moriya, M., Takamatsu, H., Nojima, S., Takegahara, N., et al. (2010). Roles of Sema4D-plexin-B1 interactions in the central nervous system for pathogenesis of experimental autoimmune encephalomyelitis. The Journal of Immunology, 184, 1499–1506. doi:10.4049/jimmunol.0903302.

    Article  CAS  PubMed  Google Scholar 

  • Perez-Miralles, F., Sastre-Garriga, J., Tintore, M., Arrambide, G., Nos, C., Perkal, H., et al. (2013). Clinical impact of early brain atrophy in clinically isolated syndromes. Multiple Sclerosis, 19, 1878–1886. doi:10.1177/1352458513488231.

    Article  CAS  PubMed  Google Scholar 

  • Piaton, G., Aigrot, M. S., Williams, A., Moyon, S., Tepavcevic, V., Moutkine, I., et al. (2011). Class 3 semaphorins influence oligodendrocyte precursor recruitment and remyelination in adult central nervous system. Brain, 134, 1156–1167. doi:10.1093/brain/awr022.

    Article  PubMed  Google Scholar 

  • Ribbons, K. A., McElduff, P., Boz, C., Trojano, M., Izquierdo, G., Duquette, P., et al. (2015). Male sex is independently associated with faster disability accumulation in relapse-onset ms but not in primary progressive MS. PLoS ONE, 10, e0122686. doi:10.1371/journal.pone.0122686.

    Article  PubMed  PubMed Central  Google Scholar 

  • Roxburgh, R. H., Seaman, S. R., Masterman, T., Hensiek, A. E., Sawcer, S. J., Vukusic, S., et al. (2005). Multiple sclerosis severity score: Using disability and disease duration to rate disease severity. Neurology, 64, 1144–1151. doi:10.1212/01.WNL.0000156155.19270.F8.

    Article  CAS  PubMed  Google Scholar 

  • Runmarker, B., & Andersen, O. (1995). Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain, 118(Pt 1), 253–261.

    Article  PubMed  Google Scholar 

  • Sahay, A., Kim, C. H., Sepkuty, J. P., Cho, E., Huganir, R. L., Ginty, D. D., et al. (2005). Secreted semaphorins modulate synaptic transmission in the adult hippocampus. Journal of Neuroscience, 25, 3613–3620. doi:10.1523/JNEUROSCI.5255-04.2005.

    Article  CAS  PubMed  Google Scholar 

  • Sobrino, A., Mata, M., Laguna-Fernandez, A., Novella, S., Oviedo, P. J., Garcia-Perez, M. A., et al. (2009). Estradiol stimulates vasodilatory and metabolic pathways in cultured human endothelial cells. PLoS ONE, 4, e8242. doi:10.1371/journal.pone.0008242.

    Article  PubMed  PubMed Central  Google Scholar 

  • Spence, R. D., & Voskuhl, R. R. (2012). Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration. Frontiers in Neuroendocrinology, 33, 105–115. doi:10.1016/j.yfrne.2011.12.001.

    Article  CAS  PubMed  Google Scholar 

  • Tran, T. S., Rubio, M. E., Clem, R. L., Johnson, D., Case, L., Tessier-Lavigne, M., et al. (2009). Secreted semaphorins control spine distribution and morphogenesis in the postnatal CNS. Nature, 462, 1065–1069. doi:10.1038/nature08628.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Waimey, K. E., Huang, P. H., Chen, M., & Cheng, H. J. (2008). Plexin-A3 and plexin-A4 restrict the migration of sympathetic neurons but not their neural crest precursors. Development Biology, 315, 448–458. doi:10.1016/j.ydbio.2008.01.002.

    Article  CAS  Google Scholar 

  • Williams, A., Piaton, G., Aigrot, M. S., Belhadi, A., Theaudin, M., Petermann, F., et al. (2007). Semaphorin 3A and 3F: Key players in myelin repair in multiple sclerosis? Brain, 130, 2554–2565. doi:10.1093/brain/awm202.

    Article  PubMed  Google Scholar 

  • Xiang, X., Zhang, X., & Huang, Q. L. (2012). Plexin A3 is involved in semaphorin 3F-mediated oligodendrocyte precursor cell migration. Neuroscience Letters, 530, 127–132. doi:10.1016/j.neulet.2012.09.058.

    Article  CAS  PubMed  Google Scholar 

  • Yaron, A., Huang, P. H., Cheng, H. J., & Tessier-Lavigne, M. (2005). Differential requirement for Plexin-A3 and -A4 in mediating responses of sensory and sympathetic neurons to distinct class 3 Semaphorins. Neuron, 45, 513–523. doi:10.1016/j.neuron.2005.01.013.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This research was funded by Kuwait Foundation for the Advancement of Science (KFAS) Grant Number 2012-1302-02.

Author’s Contributions

MQ and MH performed DNA extraction and genotyping experiments. SPJ performed the ELISA experiment. RA facilitated patient sample collection and provided clinical data of MS patients. RAA conceived the project’s design, implementation, exome sequencing, data analysis and wrote the manuscript. All authors have reviewed and approved the final manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rabeah Abbas Al-Temaimi.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Qureshi, M., Hatem, M., Alroughani, R. et al. PLXNA3 Variant rs5945430 is Associated with Severe Clinical Course in Male Multiple Sclerosis Patients. Neuromol Med 19, 286–292 (2017). https://doi.org/10.1007/s12017-017-8443-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12017-017-8443-0

Keywords

Navigation